The Indonesian Ministry of Health has officially set a policy for the second COVID-19 booster vaccine or fourth dose as of January 29, 2022. The government prioritizes health workers as recipients of the second COVID-19 booster vaccine, after it was reported that two doctors died in the new wave of Omicron.
The analysis of the second booter COVID-19 vaccine has passed the consideration of the Food and Drug Supervisory Agency (BPOM RI) and the Indonesian Technical Advisory Group on Immunization (ITAGI). The second booster COVID-19 vaccine is believed to be able to increase antibodies that may fade after six months of being vaccinated with the first booster.
If the first booster COVID-19 vaccine uses Pfizer or AstraZeneca, what type of vaccine can be used? Here’s the complete combination.
ADVERTISEMENT
SCROLL TO RESUME CONTENT
–
Pfizer’s first booster receiver:
The second booster is recommended to return to the full dose of Pfizer COVID-19 vaccine, or full dose of Moderna, and full dose of AstraZeneca.
AstraZeneca’s first booster receiver:
Can only receive Moderna and Pfizer in full doses.
Sinovac’s first booster receiver:
Can be continued with a half dose of AstraZeneca or Pfizer, Sinopharm or a full dose of Sinovac.
Sinopharm’s first booster receiver:
Can continue the second booster COVID-19 vaccination with the full dose.
“The vaccine used for the second booster follow-up dose for health human resources at the point above is adjusted to the availability of vaccines in each region, by prioritizing vaccines that have the closest expiry date,” said Director General of P2P of the Indonesian Ministry of Health, Maxi Rein Rondonuwu.
Also watch this week’s figure: Sanggar Dusk, Save Street Children from Rape to Murder
(naf/naf)
–
